• Processes broad spectrum antibacterial activity.
  • Effective in the treatment of SSTI, cUTI, LRTI, Gynecological infections & Febrile Neutropenia.
  • Show significantly higher cure rate of 93% in patients with intra-abdominal infections as compared to imipenem / cilastatin.
  • Well tolerated in the treatment of adult patients with community-acquired LRTI.
  • Piperacillin-Tazobactam is a reliable option for empiric treatment of moderate-to-severe infections in hospitalized patients.
  • Piperacillin-Tazobactam treatment results in lower all cause mortality compared to other Beta Lactam antibiotics.